Sue-Jean Lin
Director, Arcutis Biotherapeutics, Inc.
Companies
- Stevanato GroupBoard member Mar 18, 2026 to now1
- Arcutis Biotherapeutics, Inc.Board member Jun 16, 2021 to now2
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Arcutis Biotherapeutics, Inc. ARQT27,567 shares3$895.9K at $32.50Jun 15, 2026
Stevanato Group STVN6,975 shares4$131.9K at $18.91Jun 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 15, 2026Sold 4,946 shares at $24.38 of Arcutis Biotherapeutics, Inc.3
- Jun 12, 2026Granted 4,975 shares of Stevanato Group4
- Jun 5, 2026Granted 5,778 shares of Arcutis Biotherapeutics, Inc.5
- Nov 24, 2025Sold 25,272 shares at $30.78 of Arcutis Biotherapeutics, Inc.6
- Nov 24, 2025Exercised options 7,220 shares at $7.51 of Arcutis Biotherapeutics, Inc.6
- Nov 24, 2025Exercised options 18,052 shares at $8.63 of Arcutis Biotherapeutics, Inc.6
- Jun 12, 2025Granted 7,609 shares of Arcutis Biotherapeutics, Inc.7
- Jun 14, 2024Granted 10,139 shares of Arcutis Biotherapeutics, Inc.8
- May 31, 2023Granted 4,375 shares of Arcutis Biotherapeutics, Inc.9
- Jun 1, 2022Granted 4,312 shares of Arcutis Biotherapeutics, Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARStevanato Group, Board member
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jun 9, 2026
- 6SEC EDGARForm 4 filed Nov 25, 2025
- 7SEC EDGARForm 4 filed Jun 16, 2025
- 8SEC EDGARForm 4 filed Jun 18, 2024
- 9SEC EDGARForm 4 filed Jun 2, 2023
- 10SEC EDGARForm 4 filed Jun 3, 2022